SidC and SdcA Protein Fragments for Phosphoinositide Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective means to detect and quantify phosphoinositide lipids, particularly phosphatidylinositol(3) phosphate (PI(3)P), phosphatidylinositol(4) phosphate (PI(4)P), and phosphatidyl-inositol(5) phosphate (PI(5)P, and to understand their role in bacterial replication and host cell trafficking, especially in the context of Legionella pneumophila infection.
Innovation Solution
Development of novel SidC- and SdcA-derived fragments and fusion proteins that specifically bind to PI(4)P, allowing for detection, quantification, and localization of these lipids in biological samples, and utilizing these proteins as therapeutic agents for disorders related to abnormal phosphoinositide levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional detection methods are used, then general lipid detection is possible, but specific detection and quantification of phosphoinositide lipids (PI(3)P, PI(4)P, PI(5)P) cannot be achieved
Solution Approach 1:
The patent employs bacterial proteins (SidC, SdcA) and their derived fragments as intermediary binding agents that specifically recognize and bind to phosphoinositide lipids. These proteins serve as mediators between the detection system and the target lipids, enabling specific detection through their unique binding properties. The proteins can be conjugated to detection markers or used in pull-down assays to isolate and detect specific phosphoinositide species.
Solution Approach 2:
The patent creates simplified copies or fragments of the original bacterial proteins (SidC, SdcA) that retain the essential phosphoinositide-binding capability. These truncated versions or fusion proteins are easier to produce, purify, and manipulate while maintaining specific binding to target lipids, thus enabling practical detection applications without requiring the full-length complex proteins.
2Measurement precision
If bacterial proteins SidC and SdcA are used for detection, then specific binding to PI(4)P is achieved, but production and purification complexity increases
Solution Approach 1:
The patent divides the original bacterial proteins SidC and SdcA into smaller functional fragments or domains that contain the phosphoinositide-binding capability. These segmented versions are easier to express, purify, and standardize for detection assays. The segmentation allows for modular design where only the essential binding domain is required, reducing production complexity while maintaining specificity.
Solution Approach 2:
The patent creates fusion proteins that combine the phosphoinositide-binding domain of SidC or SdcA with other functional domains or tags (such as fluorescent proteins, affinity tags, or enzyme domains). These composite constructs facilitate easier purification, detection, and application while retaining the specific binding properties of the original proteins.
3Reliability
If full-length bacterial proteins are used, then binding activity is maintained, but stability and robustness for repeated use decreases
Solution Approach 1:
The patent extracts and isolates only the essential phosphoinositide-binding domain from the full-length bacterial proteins, removing unnecessary regions that may contribute to instability or complexity. This extracted core domain is more stable and robust for repeated use in detection assays while maintaining full binding activity to phosphoinositide lipids.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables specific binding and detection of PI(4)P, providing insights into bacterial replication mechanisms and potential therapeutic applications for modulating vesicle trafficking and treating diseases like Lowe syndrome.
Implementation Method 1
contacting the sample with a polypeptide and determining whether the compound binds to the phosphoinositide lipid
Data Source
AI summary
Methods for detecting and quantifying phosphoinositide lipids in a sample are provided, together with novel SidC- and SdcA-derived polypeptide fragments, or fusion proteins comprising such fragments that may be effectively employed as PI(4)P probes in biochemical and cell biological assays. Applications of the disclosed probes include: (i) detection and quantification of PI(4)P in vitro; and (ii) staining of intracellular compartments in live or fixed eukaryotic cells.